Sante Ventures
Overview
A life sciences venture capital firm investing in early-stage companies developing innovative medical technologies. Founded in 2006, Sante Ventures has nearly $1 billion in capital under management. The firm focuses on early-stage investments in biotech, medtech, and healthtech sectors, aiming to build valuable, enduring companies. Sante Ventures employs a disciplined portfolio strategy, combining deep healthcare domain expertise with an extensive network of industry contacts and resources. This approach has led to successful investments in companies like Farapulse, Claret Medical, and TVA Medical, contributing to improved patient health outcomes through advances in biology, medicine, and information technology.
Investment Focus
- Innovative medical technologies
- Early-stage companies
- Strong management teams
- Potential for significant impact on healthcare
Portfolio Companies
Reach Sante Ventures directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Sante Ventures
What sectors does Sante Ventures invest in?
Sante Ventures invests in Healthcare, HealthTech, Medtech and Biotechnology, and is based in Texas, United States. Sante Ventures is listed as a venture capital in the ConnectSafely investor database.
What stage does Sante Ventures invest at?
Sante Ventures backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage, writing cheques of 1M - 50M.
Which regions does Sante Ventures invest in?
Sante Ventures invests across United States.
What companies has Sante Ventures invested in?
Sante Ventures's portfolio includes Molecular Templates, Farapulse, Claret Medical, TVA Medical, Millipede Medical, AbVitro and Explorys.
Last updated · Source: ConnectSafely investor database
